The advanced (3D/4D) visualization systems market revenue totaled US$ 711.1 million in 2022. The overall sale is projected to reach US$ 1,139.9 million by 2033, expanding at a CAGR of 4.5% from 2023 to 2033.
| Attributes | Details |
|---|---|
| 2022 Market Value | US$ 711.1 million |
| 2023 Market Value | US$ 731.7 million |
| 2033 Market Value | US$ 1,139.9 million |
| CAGR% (2023 to 2033) | 4.5% |
| Share of Top 5 Players | 20% |
The advanced (3D/4D) visualization systems growth is going to continue to accelerate as a result of the continuous developments in medical visualization technologies. The growth of this market is driven by factors such as:
The advanced (3D/4D) visualization systems market is nearly 15.0% of the medical imaging market.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Advanced visualization systems usually provide multifunctional applications such as imaging, quantification, reporting, and archiving in areas of radiology, gynecology, obstetrics, and vascular and abdominal examinations. The availability of advanced software and the usage of high-end processors have made 3D/4D advanced visualization systems the preferred choice of modality for many physicians.
The advanced (3D/4D) visualization systems demand is estimated to rise at 4.5% CAGR between 2023 and 2033 in comparison with the 2.4% CAGR registered from 2018 to 2022.
The global advanced (3D/4D) visualization systems market is anticipated to witness an increase in revenue from US$ 731.7 million in 2023 to US$ 1,139.9 million by 2028.
Over the past few years, manufacturers have recorded a noticeable trend of tablet and smartphone adoption in the medical community. Physicians and other medical personnel are using their smart and compact mobile devices to review treatments and studies and share them with their patients.
This trend of smart mobile device adoption is estimated to increase during the forecast period, as manufacturers have started developing and marketing advanced visualization systems which showcase enhanced efficiency when connected with such smart mobile devices. This trend is expected to change the way medical experts and personnel read the studies, hence driving the advanced (3D/4D) visualization systems market.
Principal Consultant
Germany is the Leading Supplier of Advanced (3D/4D) Visualization Systems to Europe Market
Germany is predicted to remain one of the most attractive markets during the forecast period. According to the study, the country is expected to witness a CAGR of 3.1% by 2033.
One of the key trends in the advanced visualization market in Germany is the development of three-dimensional models from Magnetic Resonance Imaging (MRI) and CT scans. This development helps to guide surgical procedures and other minimally invasive treatments in hospitals. These three-dimensional models may be developed by hands-on medical experts, 3D laboratories, or 3D reconstructions outsourced and transmitted via the internet.
Various healthcare end-users in the country are outsourcing 3D model creation to advanced visualization service providers. Such factors are expected to boost the advanced (3D/4D) visualization systems market in the coming years in Germany.
| Regional Markets | Global Market Share in Percentage |
|---|---|
| The United States | 19.8% |
| Germany | 5.8% |
| Japan | 6.1% |
| Australia | 4.1% |
China and India are emerging as the Two Competitors in Asia Pacific Region
The advanced (3D/4D) visualization systems demand in Japan is expected to account for 35.9% market share of East Asia. The country is anticipated to grow in upcoming years as the country is a huge market for advanced (3D/4D) visualization systems.
The increase in medical tourism in emerging markets has led to the high adoption of advanced visualization systems in Japan. These systems enable the country to offer the best, yet cost-effective medical tourism solutions. This in turn results in a rise in several surgical procedures. Therefore, factors such as medical tourism and a growing number of patients affected with chronic diseases might propel the growth of the advanced (3D 4D) visualization systems market in Japan.
| Regional Market | CAGR (2023 to 2033) |
|---|---|
| The United Kingdom | 3.9% |
| China | 3.4% |
| India | 8.6% |
The United States to Remain at the Forefront for the Development of Cutting-edge Products
Sales in the United States are estimated to increase at an impressive rate of around 2.6% CAGR by 2033. The advanced (3D/4D) visualization systems market is significantly evolving with new technologies and methodologies in the United States.
The United States government is investing significantly in numerous initiatives to accelerate advancements in the healthcare industry. Increasing requirement for the building of automation for clinical efficiency is boosting the demand for smart healthcare devices and other related solutions in the country. This is another crucial parameter for the growth of the IoT in the healthcare market and further drives the demand for advanced (3D/4D) visualization systems.
Key players in the country such as General Electric Company, Thermo Fisher Scientific, and others are focusing on cost reduction and constantly innovating to enhance the capacity efficiency in the advanced (3D/4D) visualization systems market.
| Regional Markets Comparison | Global Market Share in Percentage |
|---|---|
| North America | 29.1% |
| Europe | 16.1% |
The Neurology Application Segment is Expected to Register a 4.2% CAGR by the end of 2033.
It is imperative to monitor patient progress over months and often years for effective treatment of neurological disorders. The progression of neurological disorders is unpredictable. Hence, immediate access to patient history is of paramount importance for a doctor to make informed decisions regarding future course of action. This requires the AV images to be adequately stored to be useful during future courses of treatment by comparing present patient data with earlier records.
PACS (Picture Archiving and Communication System) is a healthcare technology for short- and long-term storage, retrieval, management, distribution, and presentation of medical images in neurology. Thus, the application of advanced (3D/4D) visualization systems for neurology is likely to fuel market growth.
| Category | By Platform |
|---|---|
| Top Segment | CT |
| Market Share in Percentage | 32.9% |
| Category | By End User |
|---|---|
| Top Segment | Hospital |
| Market Share in Percentage | 51.2% |
The CT Platform Segment is Expected to Showcase a Strong CAGR of 4.0% over the Projected Years.
Computed tomography (CT) also known as CAT scan, is a medical imaging method that combines multiple X-ray projections taken from different angles to produce detailed cross-sectional images of areas inside the body.
Doctors are using CT platforms to acquire accurate, 3-D views of various parts of the body such as soft tissues, pelvis, blood vessels, lungs, brain, heart, abdomen, and bones. It has become the preferred method for doctors to diagnose many cancers, such as liver, lung, and pancreatic cancers. These factors are supporting the growth of the advanced (3D/4D) visualization systems market.
The Hospital End User Segment is Expected to Showcase an Impressive CAGR of 4.4% over the Forecast Period.
The number of people affected by chronic diseases continues to surge across the world. This escalates the need for access to medical procedures in hospitals. Cardiovascular diseases are the reported causes of death, globally. The population affected by heart ailments increases every year. In 2014, data from the CDC indicated that around 26.7 million, or 11.5% of adults in the United States were diagnosed with heart disease.
CT coronary angiography enables hospitals to diagnose coronary heart diseases in patients with chest pain accurately. Lower incidences of heart attacks are reported in patients receiving CT scans, compared to the usual procedures, such as a stress test. Such benefits of the various modalities in advanced visualization technology might propel the market in the forthcoming years.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Many key solution providers are inclined at investing significantly in innovation, research, and development practices. This investment is to uncover increased applications of advanced (3D/4D) visualization systems. With the use of technology, players are also focusing on reducing the cost of advanced (3D/4D) visualization systems and customer satisfaction for captivating an increased customer base.
| Attribute | Details |
|---|---|
| Market value in 2022 | US$ 711.1 million |
| Market CAGR 2023 to 2033 | 4.5% |
| Share of top 5 players | Around 20% |
| Forecast Period | 2023 to 2033 |
| Historical Data Available for | 2018 to 2022 |
| Market Analysis | US$ million or billion for Value |
| Key Regions Covered | North America; Latin America; Europe; South Asia; East Asia; Oceania & Middle East & Africa |
| Key Countries Covered | The United States, Canada, Germany, France, Italy, Spain, The United Kingdom, Benelux, Russia, Australia, New Zealand, China, Japan, South Korea, India, Malaysia, Indonesia, Australia & New Zealand, GCC Countries and South Africa |
| Key Segments Covered | Platform, End User, Application, and Region |
| Key Companies Profiled | Siemens AG; General Electric Company; Koninklijke Philips N.V.; LG Electronics Inc.; Thermo Fisher Scientific; FUJIFILM Corporation; CONMED Corporation; Pro Medicus, Ltd.; Carestream Health; Ziosoft |
| Report Coverage | Market Forecast, Company Share Analysis, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, and Strategic Growth Initiatives |
| Customization & Pricing | Available upon Request |
The market is valued at US$ 731.7 million in 2023.
Siemens AG, and General Electric Company are key market players.
The market is expected to reach US$ 1.1 billion by 2033.
Adoption of smartphones and tablets in medical community will fuel the market.
From 2018 to 2022, the market registered a CAGR of 2.4%.
1. Executive Summary 1.1. Global Market Outlook 1.2. Demand-side Trends 1.3. Supply-side Trends 1.4. Technology Roadmap Analysis 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Background 3.1. Market Dynamics 3.1.1. Drivers 3.1.2. Restraints 3.1.3. Opportunity 3.1.4. Trends 3.2. Scenario Forecast 3.2.1. Demand in Optimistic Scenario 3.2.2. Demand in Likely Scenario 3.2.3. Demand in Conservative Scenario 3.3. Opportunity Map Analysis 3.4. Investment Feasibility Matrix 3.5. PESTLE and Porter’s Analysis 3.6. Regulatory Landscape 3.6.1. By Key Regions 3.6.2. By Key Countries 3.7. Regional Parent Market Outlook 4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033 4.1. Historical Market Size Value (US$ Million) Analysis, 2018 to 2022 4.2. Current and Future Market Size Value (US$ Million) Projections, 2023 to 2033 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Platform 5.1. Introduction / Key Findings 5.2. Historical Market Size Value (US$ Million) Analysis By Platform, 2018 to 2022 5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Platform, 2023 to 2033 5.3.1. Ultrasound 5.3.2. MRI 5.3.3. CT 5.3.4. PET 5.4. Y-o-Y Growth Trend Analysis By Platform, 2018 to 2022 5.5. Absolute $ Opportunity Analysis By Platform, 2023 to 2033 6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End User 6.1. Introduction / Key Findings 6.2. Historical Market Size Value (US$ Million) Analysis By End User, 2018 to 2022 6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End User, 2023 to 2033 6.3.1. Hospitals 6.3.2. Diagnostic Laboratories 6.3.3. Academic and Research 6.4. Y-o-Y Growth Trend Analysis By End User, 2018 to 2022 6.5. Absolute $ Opportunity Analysis By End User, 2023 to 2033 7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Application 7.1. Introduction / Key Findings 7.2. Historical Market Size Value (US$ Million) Analysis By Application, 2018 to 2022 7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Application, 2023 to 2033 7.3.1. Cardiology 7.3.2. Oncology 7.3.3. Neurology 7.4. Y-o-Y Growth Trend Analysis By Application, 2018 to 2022 7.5. Absolute $ Opportunity Analysis By Application, 2023 to 2033 8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region 8.1. Introduction 8.2. Historical Market Size Value (US$ Million) Analysis By Region, 2018 to 2022 8.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023 to 2033 8.3.1. North America 8.3.2. Latin America 8.3.3. Europe 8.3.4. South Asia 8.3.5. East Asia 8.3.6. Oceania 8.3.7. MEA 8.4. Market Attractiveness Analysis By Region 9. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 9.2.1. By Country 9.2.1.1. U.S. 9.2.1.2. Canada 9.2.2. By Platform 9.2.3. By End User 9.2.4. By Application 9.3. Market Attractiveness Analysis 9.3.1. By Country 9.3.2. By Platform 9.3.3. By End User 9.3.4. By Application 9.4. Key Takeaways 10. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 10.2.1. By Country 10.2.1.1. Brazil 10.2.1.2. Mexico 10.2.1.3. Rest of Latin America 10.2.2. By Platform 10.2.3. By End User 10.2.4. By Application 10.3. Market Attractiveness Analysis 10.3.1. By Country 10.3.2. By Platform 10.3.3. By End User 10.3.4. By Application 10.4. Key Takeaways 11. Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 11.2.1. By Country 11.2.1.1. Germany 11.2.1.2. U.K. 11.2.1.3. France 11.2.1.4. Spain 11.2.1.5. Italy 11.2.1.6. Rest of Europe 11.2.2. By Platform 11.2.3. By End User 11.2.4. By Application 11.3. Market Attractiveness Analysis 11.3.1. By Country 11.3.2. By Platform 11.3.3. By End User 11.3.4. By Application 11.4. Key Takeaways 12. South Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 12.2.1. By Country 12.2.1.1. India 12.2.1.2. Malaysia 12.2.1.3. Singapore 12.2.1.4. Thailand 12.2.1.5. Rest of South Asia 12.2.2. By Platform 12.2.3. By End User 12.2.4. By Application 12.3. Market Attractiveness Analysis 12.3.1. By Country 12.3.2. By Platform 12.3.3. By End User 12.3.4. By Application 12.4. Key Takeaways 13. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 13.2.1. By Country 13.2.1.1. China 13.2.1.2. Japan 13.2.1.3. South Korea 13.2.2. By Platform 13.2.3. By End User 13.2.4. By Application 13.3. Market Attractiveness Analysis 13.3.1. By Country 13.3.2. By Platform 13.3.3. By End User 13.3.4. By Application 13.4. Key Takeaways 14. Oceania Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 14.2.1. By Country 14.2.1.1. Australia 14.2.1.2. New Zealand 14.2.2. By Platform 14.2.3. By End User 14.2.4. By Application 14.3. Market Attractiveness Analysis 14.3.1. By Country 14.3.2. By Platform 14.3.3. By End User 14.3.4. By Application 14.4. Key Takeaways 15. MEA Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 15.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 15.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 15.2.1. By Country 15.2.1.1. GCC Countries 15.2.1.2. South Africa 15.2.1.3. Israel 15.2.1.4. Rest of MEA 15.2.2. By Platform 15.2.3. By End User 15.2.4. By Application 15.3. Market Attractiveness Analysis 15.3.1. By Country 15.3.2. By Platform 15.3.3. By End User 15.3.4. By Application 15.4. Key Takeaways 16. Key Countries Market Analysis 16.1. U.S. 16.1.1. Pricing Analysis 16.1.2. Market Share Analysis, 2022 16.1.2.1. By Platform 16.1.2.2. By End User 16.1.2.3. By Application 16.2. Canada 16.2.1. Pricing Analysis 16.2.2. Market Share Analysis, 2022 16.2.2.1. By Platform 16.2.2.2. By End User 16.2.2.3. By Application 16.3. Brazil 16.3.1. Pricing Analysis 16.3.2. Market Share Analysis, 2022 16.3.2.1. By Platform 16.3.2.2. By End User 16.3.2.3. By Application 16.4. Mexico 16.4.1. Pricing Analysis 16.4.2. Market Share Analysis, 2022 16.4.2.1. By Platform 16.4.2.2. By End User 16.4.2.3. By Application 16.5. Germany 16.5.1. Pricing Analysis 16.5.2. Market Share Analysis, 2022 16.5.2.1. By Platform 16.5.2.2. By End User 16.5.2.3. By Application 16.6. U.K. 16.6.1. Pricing Analysis 16.6.2. Market Share Analysis, 2022 16.6.2.1. By Platform 16.6.2.2. By End User 16.6.2.3. By Application 16.7. France 16.7.1. Pricing Analysis 16.7.2. Market Share Analysis, 2022 16.7.2.1. By Platform 16.7.2.2. By End User 16.7.2.3. By Application 16.8. Spain 16.8.1. Pricing Analysis 16.8.2. Market Share Analysis, 2022 16.8.2.1. By Platform 16.8.2.2. By End User 16.8.2.3. By Application 16.9. Italy 16.9.1. Pricing Analysis 16.9.2. Market Share Analysis, 2022 16.9.2.1. By Platform 16.9.2.2. By End User 16.9.2.3. By Application 16.10. India 16.10.1. Pricing Analysis 16.10.2. Market Share Analysis, 2022 16.10.2.1. By Platform 16.10.2.2. By End User 16.10.2.3. By Application 16.11. Malaysia 16.11.1. Pricing Analysis 16.11.2. Market Share Analysis, 2022 16.11.2.1. By Platform 16.11.2.2. By End User 16.11.2.3. By Application 16.12. Singapore 16.12.1. Pricing Analysis 16.12.2. Market Share Analysis, 2022 16.12.2.1. By Platform 16.12.2.2. By End User 16.12.2.3. By Application 16.13. Thailand 16.13.1. Pricing Analysis 16.13.2. Market Share Analysis, 2022 16.13.2.1. By Platform 16.13.2.2. By End User 16.13.2.3. By Application 16.14. China 16.14.1. Pricing Analysis 16.14.2. Market Share Analysis, 2022 16.14.2.1. By Platform 16.14.2.2. By End User 16.14.2.3. By Application 16.15. Japan 16.15.1. Pricing Analysis 16.15.2. Market Share Analysis, 2022 16.15.2.1. By Platform 16.15.2.2. By End User 16.15.2.3. By Application 16.16. South Korea 16.16.1. Pricing Analysis 16.16.2. Market Share Analysis, 2022 16.16.2.1. By Platform 16.16.2.2. By End User 16.16.2.3. By Application 16.17. Australia 16.17.1. Pricing Analysis 16.17.2. Market Share Analysis, 2022 16.17.2.1. By Platform 16.17.2.2. By End User 16.17.2.3. By Application 16.18. New Zealand 16.18.1. Pricing Analysis 16.18.2. Market Share Analysis, 2022 16.18.2.1. By Platform 16.18.2.2. By End User 16.18.2.3. By Application 16.19. GCC Countries 16.19.1. Pricing Analysis 16.19.2. Market Share Analysis, 2022 16.19.2.1. By Platform 16.19.2.2. By End User 16.19.2.3. By Application 16.20. South Africa 16.20.1. Pricing Analysis 16.20.2. Market Share Analysis, 2022 16.20.2.1. By Platform 16.20.2.2. By End User 16.20.2.3. By Application 16.21. Israel 16.21.1. Pricing Analysis 16.21.2. Market Share Analysis, 2022 16.21.2.1. By Platform 16.21.2.2. By End User 16.21.2.3. By Application 17. Market Structure Analysis 17.1. Competition Dashboard 17.2. Competition Benchmarking 17.3. Market Share Analysis of Top Players 17.3.1. By Regional 17.3.2. By Platform 17.3.3. By End User 17.3.4. By Application 18. Competition Analysis 18.1. Competition Deep Dive 18.1.1. Siemens AG 18.1.1.1. Overview 18.1.1.2. Product Portfolio 18.1.1.3. Profitability by Market Segments 18.1.1.4. Sales Footprint 18.1.1.5. Strategy Overview 18.1.1.5.1. Marketing Strategy 18.1.2. General Electric Company 18.1.2.1. Overview 18.1.2.2. Product Portfolio 18.1.2.3. Profitability by Market Segments 18.1.2.4. Sales Footprint 18.1.2.5. Strategy Overview 18.1.2.5.1. Marketing Strategy 18.1.3. Koninklijke Philips N.V. 18.1.3.1. Overview 18.1.3.2. Product Portfolio 18.1.3.3. Profitability by Market Segments 18.1.3.4. Sales Footprint 18.1.3.5. Strategy Overview 18.1.3.5.1. Marketing Strategy 18.1.4. LG Electronics Inc. 18.1.4.1. Overview 18.1.4.2. Product Portfolio 18.1.4.3. Profitability by Market Segments 18.1.4.4. Sales Footprint 18.1.4.5. Strategy Overview 18.1.4.5.1. Marketing Strategy 18.1.5. Thermo Fisher Scientific 18.1.5.1. Overview 18.1.5.2. Product Portfolio 18.1.5.3. Profitability by Market Segments 18.1.5.4. Sales Footprint 18.1.5.5. Strategy Overview 18.1.5.5.1. Marketing Strategy 18.1.6. FUJIFILM Corporation 18.1.6.1. Overview 18.1.6.2. Product Portfolio 18.1.6.3. Profitability by Market Segments 18.1.6.4. Sales Footprint 18.1.6.5. Strategy Overview 18.1.6.5.1. Marketing Strategy 18.1.7. CONMED Corporation 18.1.7.1. Overview 18.1.7.2. Product Portfolio 18.1.7.3. Profitability by Market Segments 18.1.7.4. Sales Footprint 18.1.7.5. Strategy Overview 18.1.7.5.1. Marketing Strategy 18.1.8. Pro Medicus, Ltd. 18.1.8.1. Overview 18.1.8.2. Product Portfolio 18.1.8.3. Profitability by Market Segments 18.1.8.4. Sales Footprint 18.1.8.5. Strategy Overview 18.1.8.5.1. Marketing Strategy 18.1.9. Carestream Health 18.1.9.1. Overview 18.1.9.2. Product Portfolio 18.1.9.3. Profitability by Market Segments 18.1.9.4. Sales Footprint 18.1.9.5. Strategy Overview 18.1.9.5.1. Marketing Strategy 18.1.10. Ziosoft 18.1.10.1. Overview 18.1.10.2. Product Portfolio 18.1.10.3. Profitability by Market Segments 18.1.10.4. Sales Footprint 18.1.10.5. Strategy Overview 18.1.10.5.1. Marketing Strategy 19. Assumptions & Acronyms Used 20. Research Methodology
Explore Technology Insights
View Reports
Advanced (3D/4D) Visualization Systems Market
